â‚©
6320.00
May 3
Business Description
Kyung Dong Pharmaceutical Co Ltd
ISIN : KR7011040003
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.09 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -1.39 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.04 | |||||
Beneish M-Score | -3.31 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.4 | |||||
3-Year FCF Growth Rate | 13.2 | |||||
3-Year Book Growth Rate | -3.9 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.02 | |||||
9-Day RSI | 46.31 | |||||
14-Day RSI | 46.01 | |||||
6-1 Month Momentum % | -0.31 | |||||
12-1 Month Momentum % | -14.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.54 | |||||
Days Inventory | 168.71 | |||||
Days Sales Outstanding | 42.94 | |||||
Days Payable | 24.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.33 | |||||
3-Year Dividend Growth Rate | -7.2 | |||||
Forward Dividend Yield % | 6.33 | |||||
5-Year Yield-on-Cost % | 7.78 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 4.35 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.96 | |||||
Operating Margin % | -15.34 | |||||
Net Margin % | -12.94 | |||||
FCF Margin % | -5.24 | |||||
ROE % | -8.6 | |||||
ROA % | -7.1 | |||||
ROIC % | -12.24 | |||||
ROC (Joel Greenblatt) % | -15.73 | |||||
ROCE % | -6.82 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 11.75 | |||||
PS Ratio | 1.05 | |||||
PB Ratio | 0.75 | |||||
Price-to-Tangible-Book | 0.77 | |||||
EV-to-EBIT | -9.16 | |||||
EV-to-EBITDA | -14 | |||||
EV-to-Revenue | 0.95 | |||||
EV-to-FCF | -18.16 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Price-to-Net-Current-Asset-Value | 6.87 | |||||
Earnings Yield (Greenblatt) % | -10.92 | |||||
FCF Yield % | -4.97 | |||||
Forward Rate of Return (Yacktman) % | -14.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kyung Dong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 162,674.099 | ||
EPS (TTM) (â‚©) | -776 | ||
Beta | 0.71 | ||
Volatility % | 13.59 | ||
14-Day RSI | 46.01 | ||
14-Day ATR (â‚©) | 84.207228 | ||
20-Day SMA (â‚©) | 6302.5 | ||
12-1 Month Momentum % | -14.19 | ||
52-Week Range (â‚©) | 6120 - 8420 | ||
Shares Outstanding (Mil) | 26.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kyung Dong Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kyung Dong Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kyung Dong Pharmaceutical Co Ltd Frequently Asked Questions
What is Kyung Dong Pharmaceutical Co Ltd(XKRX:011040)'s stock price today?
When is next earnings date of Kyung Dong Pharmaceutical Co Ltd(XKRX:011040)?
Does Kyung Dong Pharmaceutical Co Ltd(XKRX:011040) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |